Schedule 13G ownership disclosure

TONIX PHARMACEUTICALS HOLDIN

Security class unavailable · CUSIP: 890260706

Event date: 2019-11-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
210,000
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-19-009015
Form type
SC 13G
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Nov 25, 2019
Reporting period
Nov 15, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub